Design of Physicians' Health Study II - A randomized trial of beta-carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials

Annals of Epidemiology

Volumn 10, Issue 2, 2000, Pages 125-134

  Christen, William G ^a   Gaziano, J Michael ^a,b   Hennekens, Charles H ^c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b VA BOSTON HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Age related cataract; Age related macular degeneration; Antioxidant vitamins; Cancer; Cardiovascular disease; Randomized trial

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; MULTIVITAMIN; PLACEBO;

ADULT; AGED; ARTICLE; CANCER; CANCER PREVENTION; CANCER RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EYE DISEASE; HUMAN; MALE; NORMAL HUMAN; PHYSICIAN; PRIMARY PREVENTION; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RETINA MACULA AGE RELATED DEGENERATION; SENILE CATARACT;

AGED; ASCORBIC ACID; BETA CAROTENE; CARDIOVASCULAR DISEASES; CATARACT; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; NEOPLASMS; SAMPLE SIZE; VITAMIN E;

EID: 0033954030     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1047-2797(99)00042-3     Document Type: Article

References (84)

1. Hennekens C.H., Eberlein K.A., for the Physicians' Health Study Research Group A randomized trial of aspirin and β-carotene among U.S. physicians. Prev Med. 14:1985;165-168.
2. Marnett L.J. Peroxy free radicals. Potential mediators of tumor initiation and promotion Carcinogenesis. 8:1987;1365-1373.
3. Breimer L.H. Molecular mechanisms of oxygen radical carcinogenesis and mutagenesis. The role of DNA base damage Mol Carcinogen. 3:1990;188-197.
4. Tappel A.L. Lipid peroxidation damage to cell components. Fed Proc. 32:1973;1870-1874.
5. Niki E. Antioxidants in the relation to lipid peroxidation. Chem Physic Lipids. 44:1987;227-253.
6. Buring J.E., Hennekens C.H. Retinoids and carotenoids. De Vita V.T. Jr., Hellman S., Rosenberg S.A. Cancer. Principles and Practice of Oncology 4th ed:1993;JB Lippincott, Philadelphia.
7. v. 2. Carotenoids. 1998;137-219 International Agency for Research on Cancer, Lyon, France.
8. Hirayama T. Epidemiology of prostate cancer with special references to the role of diet. NCI Monogr. 53:1979;149-155.
9. Graham S., Mettlin C., Marshall J., Priore R., Rzepka T., Shedd D. Dietary factors in the epidemiology of cancer of the larynx. Am J Epidemiol. 113:1981;675-680.
10. Shekelle R.B., Lepper M., Liu S., Maliza C., Raynor W.J. Jr., Rossof A.H.et al. Dietary vitamin A and risk of cancer in the Western Electric Study. Lancet. 2:1981;1186-1190.
11. Peto R., Doll R., Buckley J.D., Sporn M.B. Can dietary beta carotene materially reduce human cancer rates? Nature. 290:1981;201-208.
12. Kolonel L.N., Nomura A.M., Hinds M.W., Hirohata T., Hankin J.H., Lee J. Role of diet in cancer incidence in Hawaii. Cancer Res. 43:1983;2037S-2040S.
13. Graham S. Results of case-control studies of diet and cancer in Buffalo, New York. Cancer Res. 43:1983;2409S-2413S.
14. Colditz G.A., Branch L.G., Lipnick R.J., Willett W.C., Rosner B., Posner B.M.et al. Increased green and yellow vegetable intake and lowered cancer deaths in an elderly population. Am J Clin Nutr. 41:1985;32-36.
15. Ross R.K., Shimizu H., Paganini-Hill Honda G., Henderson B.E. Case-control study of prostate cancer in blacks and whites in Southern California. J Natl Cancer Inst. 78:1987;869-874.
16. Ohno Y., Yoshida O., Oishi K., Okada K., Yamabe H., Shroeder F.H. Dietary beta-carotene and cancer of the prostate. A case-control study in Kyoto, Japan Cancer Res. 48:1988;1331-1336.
17. Knekt P. Vitamin E and cancer. epidemiology Ann NY Acad Sci. 669:1992;269-279.
18. Howe G.R., Hirohata T., Hislop T.G., Iscovich J.M., Yuan J.M. Dietary factors and risk of breast cancer. combined analysis of 12 case-control studies J Natl Cancer Inst. 82:1990;561-569.
19. Block G. Vitamin C and cancer prevention. the epidemiologic evidence Am J Clin Nutr. 53:1991;270S-282S.
20. Byers T., Buerrero N. Epidemiologic evidence for vitamin C and vitamin E in cancer prevention. Am J Clin Nutr. 62(suppl):1995;1385S-1392S.
21. Knekt P. Human data on vitamin E and cancer. Gray G.A., Ryan D.H. Vitamins and Cancer Prevention. 1993;256-269 Louisiana State Univ Press, Baton Rouge, LA.
22. Comstock G.W., Helzlsouer K.J., Bush T.L. Prediagnostic serum levels of carotenoids and vitamin E as related to subsequent cancer in Washington County, Maryland. Am J Clin Nutr. 53:1991;260S-264S.
23. Blot W.J., Li J.Y., Taylor P.R., Guo W., Dawsey S., Wang G.Q.et al. Nutrition intervention trials in Linxian, China. Supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population J Natl Cancer Inst. 85:1993;1483-1492.
24. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med. 330:1994;1029-1035.
25. Omenn G.S., Goodman G.E., Thornquist M.D., Balmes J., Cullen M.R., Glass A.et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med. 334:1996;1150-1155.
26. Hennekens C.H., Buring J.E., Manson J.E., Stampfer M., Rosner B., Cook N.R.et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med. 334:1996;1145-1149.
27. Cook N.R., Stampfer M.J., Ma J., Manson J.E., Sacks F.M., Buring J.E.et al. β-carotene supplementation for patients with low baseline levels and decreased risks of total and prostate carcinoma. Cancer. 86:1999;1783-1792.
28. Steinberg D., Parthasarathy S., Care T.E., Khoo J.C., Witztum J.L. Beyond cholesterol. modifications of low-density lipoprotein that increase its atherogenicity N Engl J Med. 320:1989;915-924.
29. Esterbauer H., Gebicki J., Puhl H., Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med. 13:1992;341-390.
30. Keaney J.F. Jr., Gaziano J.M., Xu A., Frei B., Curran-Celentano J., Shwaery G.T.et al. Dietary antioxidants preserve endothelium-dependent vessel relaxation in cholesterol-fed rabbits. Proc Natl Acad Sci USA. 90:1993;11880-11884.
31. Acheson R.M., Williams D.R.R. Does consumption of fruit and vegetables protect against stroke? Lancet. 1:1991;1191-1193.
32. Armstrong B.K., Mann J.L., Adelstein A.M., Weskin F. Commodity consumption and ischemic heart disease mortality, with special reference to dietary practices. J Chronic Dis. 36:1975;673-677.
33. Verlangieri A.J., Kapeghian J.C., El-Dean S., Bush M. Fruit and vegetable consumption and cardiovascular disease mortality. Med Hypothes. 16:1985;7-15.
34. Ginter E. Decline of coronary mortality in the United States and vitamin C. Am J Clin Nutr. 32:1979;511-512.
35. Gey K.F., Brubacher G.B., Stahelin H.B. Plasma levels of antioxidant vitamins in relation to ischemic heart disease and cancer. Am J Clin Nutr. 45:1987;1368-1377.
36. Riemersma R.A., Oliver M., Elton R.A., Alfthan G., Vartiainen E., Salo M.et al. Plasma antioxidants and coronary heart disease. Vitamins C and E, and selenium Eur J Clin Nutr. 44:1990;143-150.
37. Vollset S.E., Bjelke E. Does consumption of fruit and vegetables protect against stroke? Lancet. 2:1983;742.
38. Salonen J.T., Salonen R., Penttila I., Herranen J., Jauhiainen M., Kantola M.et al. Serum fatty acids, apolipoproteins, selenium and vitamin antioxidants and risk of death from coronary artery disease. Am J Cardiol. 56:1985;226-231.
39. Kok F.J., de Bruijn A.M., Vermeeren R., Hofman A., van Laar A., de Bruin M.et al. Serum selenium, vitamin antioxidants and cardiovascular mortality. A 9-year follow-up study in the Netherlands Am J Clin Nutr. 45:1987;462-468.
40. Gey K.F., Stahelin H.B., Eichholzer M. Poor plasma status of carotene and vitamin C is associated with higher mortality from ischemic heart disease and stroke. Prospective Basel Study Clin Invest. 7:1993;3-6.
41. Stampfer M.J., Hennekens C.H., Manson J.E., Colditz G.A., Rosner B., Willett W.C. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med. 328:1993;1444-1449.
42. Gaziano J.M., Manson J.E., Branch L.G., Colditz G.A., Willett W.C., Buring J.E. A prospective study of consumption of carotenoids in fruits and vegetables and decreased cardiovascular mortality in the elderly. Ann Epidemiol. 5:1995;255-260.
43. Rimm E.B., Stampfer M.J., Ascherio A., Giovannucci E., Colditz G.A., Willett W.C. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med. 328:1993;1450-1456.
44. Enstrom J.E., Kanim L.E., Klein M.A. Vitamin C intake and mortality among a sample of the United States population. Epidemiology. 3:1992;194-202.
45. Gaziano J.M., Manson J.E., Hennekens C.H. Natural antioxidants and cardiovascular disease. Observational epidemiologic studies and randomized trials Frei B. Natural Antioxidants in Human Health and Disease. 1994;387-409 Academic Press, San Diego.
46. Manson J.E., Stampfer M.J., Willett W.C., Colditz G.A., Rosner B., Speizer F.E. A prospective study of antioxidant vitamins and incidence of coronary heart disease in women. Circulation. 84(suppl II):1991;546.
47. Stephens N.G., Parsons A., Schofield P.M., Kelly F., Cheeseman K., Mitchinson M.J.et al. Randomized controlled trial of vitamin E in patients with coronary disease. Cambridge Heart Antioxidant Study (CHAOS) Lancet. 347:1996;781-786.
48. Gaziano J.M., Manson J.E., Ridker P.M., Buring J.E., Hennekens C.H. Beta carotene therapy for chronic stable angina. Circulation. 82(suppl III):1990;202.
49. Steinberg D and Workshop Participants. Antioxidants in the prevention of human atherosclerosis: Summary of the proceedings of a National Heart, Lung and Blood Institute Workshop. September 5-6, 1991, Bethesda, Maryland. Circulation. 1992;85:2337-2344.
50. National Advisory Eye Council. Vision Research, a National Plan, 1994-1998. NIH Publication No. 93-3186. Bethesda, MD: U.S. Dept. of Health and Human Services.
51. Gerster H. Antioxidant vitamins in cataract prevention. Z Ernahrungswiss. 28:1989;56-75.
52. Taylor A. Role of nutrients in delaying cataracts. Ann NY Acad Sci. 669:1992;111-123.
53. Organisciak D.T., Wang H.M., Li Z.-Y., Tso M.O.M. The protective effect of ascorbate in retinal light damage of rats. Invest Ophthalmol Vis Sci. 26:1985;1580-1588.
54. Ham W.T. Jr., Mueller H.A., Ruffolo J.J. Jr., Millen J.E., Clearly S.F., Guerry R.K.et al. Basic mechanisms underlying the production of photochemical lesions in the mammalian retina. Curr Eye Res. 3:1984;165-174.
55. Tso M.O.M. Experiments on visual cells by nature and man. In search of treatment for photoreceptor degeneration Friedenwald Lecture. Invest Ophthalmol Vis Sci. 30:1989;2430-2454.
56. Jacques P.F., Hartz S.C., Chylack L.T., McGandy R.B., Sadowski J.A. Nutritional status in persons with and without senile cataract. Blood vitamin and mineral levels Am J Clin Nutr. 48:1988;152-158.
57. Robertson J.M., Donner A.P., Trevithick J.R. Vitamin E intake and risk of cataracts in humans. Ann NY Acad Sci. 570:1989;372-382.
58. Mohan M., Sperduto R.D., Angra S.K., Milton R.C., Mathur R.L., Underwood B.A.et al. India-US case-control study of age-related cataracts. Arch Ophthalmol. 107:1989;670-676.
59. Risk factors for age-related cortical, nuclear, and posterior subcapsular cataracts. Am J Epidemiol. 133:1991;541-553.
60. Leske M.C., Chylack L.T., Wu S.-Y. The Lens Opacities Case-Control Study. Risk factors for cataract Arch Ophthalmol. 109:1991;244-251.
61. Hankinson S.E., Stampfer M.J., Seddon J.M., Colditz G.A., Rosner B., Speizer F.E.et al. Nutrient intake and cataract extraction in women. A prospective study Br Med J. 305:1992;335-339.
62. Vitale S., West S., Hallfrisch J., Alston C., Wang F., Moorman C.et al. Plasma antioxidants and risk of cortical and nuclear cataract. Epidemiology. 4:1993;195-203.
63. Mares-Perlman J.A., Klein B.E.K., Klein R., Ritter L.L. Relation between lens opacities and vitamin and mineral supplement use. Ophthalmology. 101:1994;315-325.
64. Seddon J.M., Christen W.G., Manson J.E., Glynn R.J., LaMotte F.S., Buring J.E.et al. A prospective cohort study of vitamin supplements and risk of cataract among U.S. male physicians. Am J Pub Health. 84:1994;788-792.
65. Mares-Perlman J.A., Brady W.E., Klein B.E.K., Klein R., Palta M., Bowen P.et al. Serum carotenoids and tocopherols and severity of nuclear and cortical opacities. Invest Ophthalmol Vis Sci. 36:1995;276-288.
66. Leske M.C., Wu S.-Y., Hyman L., Sperduto R., Underwood B., Chylack L.et al. Biochemical factors in the Lens Opacities Case-Control Study. Arch Ophthalmol. 113:1995;1113-1119.
67. Mares-Perlman J.A., Brady W.E., Klein B.E.K., Klein R., Haus G.J., Palta M.et al. Diet and nuclear lens opacities. Am J Epidemiol. 141:1995;322-334.
68. Goldberg J., Flowerdew G., Smith E., Brody J.A., Tso M.O.M. Factors associated with age-related AMD. Analysis of data from the first National Health and Nutrition Examination Survey. Am J Epidemiol. 128:1988;700-710.
69. Antioxidant status and neovascular age-related macular degeneration. Arch Ophthalmol. 111:1993;104-109.
70. Risk factors for neovascular age-related macular degeneration. Arch Ophthalmol. 110:1992;1701-1708.
71. Mares-Perlman J.A., Brady W.E., Klein R., Klein B.E., Bowen P., Stacewicz-Sapuntzakis M.et al. Serum antioxidants and age-related macular degeneration in a population-based case-control study. Arch Ophthalmol. 113:1995;1518-1523.
72. Seddon J.M., Ajani U.A., Sperduto R.D., Hiller R., Blair N., Burton T.C.et al. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. JAMA. 272:1994;1413-1420.
73. West S., Vitale S., Hallfrisch J., Munoz B., Muller D., Bressler S.et al. Are antioxidants or supplements protective for age-related macular degeneration? Arch Ophthalmol. 112:1994;222-227.
74. Mares-Perlman J.A., Klein R., Klein B.E.K., Greger J.L., Brady W.E., Palta M.et al. Association of zinc and antioxidant nutrients with age-related maculopathy. Arch Ophthalmol. 114:1996;991-997.
75. Christen W.G., Ajani U.A., Glynn R.J., Manson J.E., Schaumberg D.A., Chew E.C.et al. A prospective cohort study of antioxidant vitamin supplement use and the risk of age-related maculopathy. Am J Epidemiol. 149:1999;476-484.
76. Sperduto R.D., Ferris F.L. III, Kurinij N. Do we have a nutritional treatment for age-related cataract or macular degeneration? Arch Ophthalmol. 108:1990;1403-1405.
77. Manual of Procedures. Bethesda, MD: National Eye Institute; 1991.
78. Buring J.E., Hennekens C.H. The Women's Health Study. summary of the study design J Myocard Ischem. 4:1992;27-29.
79. Manson J.E., Gaziano J.M., Spelsberg A., Ridker P.M., Cook N.R., Buring J.E.et al. A secondary prevention trial of antioxidant vitamins and cardiovascular disease in women. Rationale, design, and methods Ann Epidemiol. 5:1995;261-269.
80. Hennekens C.H. Issues in the design and conduct of clinical trials. J Natl Cancer Inst. 73:1984;1473-1476.
81. Lang J.M., Buring J.E., Rosner B., Cook N., Hennekens C.H. Estimating the effect of the run-in on the power of the Physicians' Health Study. Stat Med. 10:1991;1585-1593.
82. The HOPE (Heart Outcomes Prevention Evaluation) Study. The design of a large, simple randomized trial of an angio-tensin-converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events. Can J Cardiol. 12:1996;127-137.
83. Hercberg S., Galan P., Preziosi Roussel A.-M., Arnaud J., Richard M.-J.et al. Background and rationale behind the SU.VI.MAX study, a prevention trial using nutritional doses of a combination of antioxidant vitamins and minerals to reduce cardiovascular diseases and cancers. Intl J Vitam Nutr Res. 68:1998;3-20.
84. Jha P., Flather M., Lonn E., Farkouh M., Yusuf S. The antioxidant vitamins and cardiovascular disease. A critical review of epidemiologic and clinical trial data. Ann Intern Med. 123:1995;860-872.